AzTrials
AzTrials

the Difficulty of Colonoscopy InsertionNCT07228715

A Study on a New Indicator for Assessing the Difficulty of Colonoscopy Insertion and Its Related Factors

An observational study of the Difficulty of Colonoscopy Insertion, run by Second Hospital of Jilin University at 1 site in China.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study will include adult patients undergoing painless colonoscopy at our hospital. The time required for endoscope insertion to reach the cecum (Cecal Intubation Time, CIT) by physicians of different experience levels will be recorded. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
the Difficulty of Colonoscopy Insertion
How many people
2,000 participants
Where
1 siteChina
Study dates
1 Jun 2025to Apr 2026
How long will I take part?
3 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who undergo colonoscopy at the Second Hospital of Jilin University

Who may be able to join

  • Patients who voluntarily undergo colonoscopy

Who cannot join

  • patients who failed to complete the colonoscopy

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University

    Changchun, Jilin, 130000

Other trials in China

About this study

This study will include adult patients undergoing painless colonoscopy at our hospital. The time required for endoscope insertion to reach the cecum (Cecal Intubation Time, CIT) by physicians of different experience levels will be recorded. CIT roughly reflects the difficulty of colonoscope insertion, which holds important clinical significance and is associated with factors such as abdominal pain, bloating, and the degree of intestinal adhesion. However, due to confounding factors such as operator experience and equipment variability, the objectivity of CIT as an indicator of insertion difficulty is reduced.

In this study, all patients' CIT data will be standardized using three different methods: Z-score standardization, median standardization, and quantile normalization. The goal is to determine which standardized form of CIT can more objectively reflect insertion difficulty and its correlation with important clinical indicators.

The purpose of this study is to establish a novel indicator that can objectively assess colonoscope insertion difficulty across different operating environments, thereby providing a scientific basis for the development of clinical treatment strategies.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07228715
Study groupRoleWhat they receive
Junior Doctor GroupNot described
Senior Doctor GroupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time Required for Insertion to the Cecum (Cecal Intubation Time, CIT)

    Measured: From enrollment to the end of treatment at 1 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2025
  2. Study start1 Jun 2025
  3. Primary completionApr 2026 (estimated)
  4. Study completionApr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
2,000 participants (estimated)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07228715
Sponsor's protocol ID
2024467
Status last verified
Nov 2025
First submitted
13 Nov 2025
Last updated
14 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Protect patients' privacy

Publications

  • Dincer B, Omeroglu S, Guven O, Akgun IE, Celayir MF, Gurbulak EK, Yazici P, Koksal HM, Demir U. Factors predict prolonged colonoscopy before the procedure: prospective registry study. Surg Endosc. 2024 Oct;38(10):5704-5711. doi: 10.1007/s00464-024-11075-4. Epub 2024 Aug 13.

    PubMed 39138684
  • Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009 Mar;69(3 Pt 2):620-5. doi: 10.1016/j.gie.2008.05.057. Epub 2009 Jan 10.

    PubMed 19136102
  • Zhang Y, Wei L, Wang X, Tian Y, Duan R. Novel indicator for colonoscopy insertion difficulty and its application in predictive modelling: a multicentre prospective study protocol in China. BMJ Open. 2026 Jul 28;16(7):e120743. doi: 10.1136/bmjopen-2026-120743.

    PubMed 42521303

Questions about this trial

What is this clinical trial studying?

An observational study of the Difficulty of Colonoscopy Insertion, run by Second Hospital of Jilin University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 14 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time Required for Insertion to the Cecum (Cecal Intubation Time, CIT) (time frame: From enrollment to the end of treatment at 1 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07228715, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in